Literature DB >> 21173931

Influenza vaccination coverage in the 2004/05, 2005/06, and 2006/07 seasons: a secondary data analysis based on billing data of the German associations of statutory health insurance physicians.

Annicka M Reuss1, Dietmar Walter, Marcel Feig, Lutz Kappelmayer, Udo Buchholz, Tim Eckmanns, Gabriele Poggensee.   

Abstract

BACKGROUND: The German Standing Committee on Vaccination recommends annual vaccination for persons in high-risk groups in order to lower the disease burden associated with seasonal influenza. The stated target is 75% vaccination coverage of people over age 60 by the year 2010. We present statistics based on billing data of the German associations of statutory health insurance physicians regarding vaccination coverage for influenza in the three seasons from 2004/05 to 2006/07.
METHODS: We analyzed anonymous data from 14 of the 17 associations of statutory health insurance physicians in Germany. The study population consisted of all persons covered by statutory health insurance in the geographical areas under study (61.5 million persons, or 86% of the total population of these areas). Vaccination coverage was calculated as the number of vaccinated persons divided by the number of persons covered by statutory health insurance.
RESULTS: The influenza vaccination coverage of the overall study population was 19% in 2004/05, 22% in 2005/06, and 21% in 2006/07. The coverage of persons over age 60 was 45% in 2004/05, 50% in 2005/06, and 49% in 2006/07 and was higher in areas that were formerly part of East Germany than in the rest of the country. More than a third of all vaccinated persons were vaccinated in all three seasons, as were almost half of the vaccinated persons over age 60.
CONCLUSION: There was no secular increase in influenza vaccination coverage over the period 2005/06 to 2006/07. The stated target of 75% vaccination coverage for persons over age 60 by the year 2010 would thus seem to represent a major challenge for all persons involved. The analysis of data of the associations of statutory health insurance physicians enables continuous monitoring of influenza vaccination coverage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21173931      PMCID: PMC3004371          DOI: 10.3238/arztebl.2010.0845

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  9 in total

1.  [Determination of vaccination coverage and disease incidence using statutory health insurance data].

Authors:  A Reuss; M Feig; L Kappelmayer; T Eckmanns; G Poggensee
Journal:  Gesundheitswesen       Date:  2010-05-04

2.  Trends in influenza vaccination coverage rates in Germany over six seasons from 2001/02 to 2006/07.

Authors:  Patricia R Blank; Andreas U Freiburghaus; Bernhard R Ruf; Matthias M Schwenkglenks; Thomas D Szucs
Journal:  Med Klin (Munich)       Date:  2009-01-23

3.  Vaccination coverage rates in eleven European countries during two consecutive influenza seasons.

Authors:  Patricia R Blank; Matthias Schwenkglenks; Thomas D Szucs
Journal:  J Infect       Date:  2009-04-17       Impact factor: 6.072

Review 4.  Vaccination against classical influenza in health-care workers: self-protection and patient protection.

Authors:  Sabine Wicker; Holger F Rabenau; Volkhard A J Kempf; Christian Brandt
Journal:  Dtsch Arztebl Int       Date:  2009-09-04       Impact factor: 5.594

5.  [Physicians as key communicators of the influenza vaccination for the elderly, patients with chronic conditions, and health care workers. Results of a nationwide survey in the context of the national influenza vaccination campaign].

Authors:  S Wortberg; D Walter; M v d Knesebeck; S Reiter
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2009-10       Impact factor: 1.513

Review 6.  Patient reminder and patient recall systems to improve immunization rates.

Authors:  Julie C Jacobson Vann; Peter Szilagyi
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

7.  Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons.

Authors:  Patricia R Blank; Matthias Schwenkglenks; Thomas D Szucs
Journal:  BMC Public Health       Date:  2008-08-01       Impact factor: 3.295

8.  Trends in influenza vaccination coverage rates in Germany over five seasons from 2001 to 2006.

Authors:  Majbrit V Holm; Patricia R Blank; Thomas D Szucs
Journal:  BMC Infect Dis       Date:  2007-12-10       Impact factor: 3.090

Review 9.  Complications of viral influenza.

Authors:  Michael B Rothberg; Sarah D Haessler; Richard B Brown
Journal:  Am J Med       Date:  2008-04       Impact factor: 4.965

  9 in total
  13 in total

Review 1.  Vaccination recommendations for Germany.

Authors:  Miriam Wiese-Posselt; Christine Tertilt; Fred Zepp
Journal:  Dtsch Arztebl Int       Date:  2011-11-04       Impact factor: 5.594

2.  Strategies for Improving Influenza Vaccination Rates in Patients with Chronic Renal Disease.

Authors:  Kevin Schulte; Helen Schierke; Miguel Tamayo; Lutz Hager; Roland Engehausen; Matthias Raspe; Ralf-Harto Hübner; Georg Schlieper; Christoph Borzikowsky; Andreas Urbschat; Sven Auerswald; Ulrich Kunzendorf; Thorsten Feldkamp
Journal:  Dtsch Arztebl Int       Date:  2019-06-10       Impact factor: 5.594

3.  Understandable skepticism.

Authors:  Doris Nienborg
Journal:  Dtsch Arztebl Int       Date:  2011-04-15       Impact factor: 5.594

4.  [Analysis of vaccination data of patients aged 60 years and older from Bavaria and Thuringia].

Authors:  Anja Kwetkat; Thomas Lehmann; Sarah Weinberger; Jörg Schelling
Journal:  Z Gerontol Geriatr       Date:  2015-06-26       Impact factor: 1.281

5.  Influenza and pneumococcal vaccination in patients with rheumatoid arthritis in comparison with age- and sex-matched controls: results of a claims data analysis.

Authors:  A Luque Ramos; F Hoffmann; J Callhoff; A Zink; K Albrecht
Journal:  Rheumatol Int       Date:  2016-07-02       Impact factor: 2.631

6.  [Medical treatment of rheumatoid arthritis in 2014 : Current data from the German Collaborative Arthritis Centers].

Authors:  K Albrecht; D Huscher; T Eidner; S Kleinert; S Späthling-Mestekemper; S Bischoff; A Zink
Journal:  Z Rheumatol       Date:  2017-02       Impact factor: 1.372

7.  Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany.

Authors:  Cornelius Remschmidt; Thorsten Rieck; Birte Bödeker; Ole Wichmann
Journal:  BMC Infect Dis       Date:  2015-03-20       Impact factor: 3.090

8.  Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study.

Authors:  Birte Bödeker; Cornelius Remschmidt; Patrick Schmich; Ole Wichmann
Journal:  BMC Public Health       Date:  2015-07-07       Impact factor: 3.295

9.  Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010/2011 season.

Authors:  H Englund; H Campe; W Hautmann
Journal:  Epidemiol Infect       Date:  2012-10-26       Impact factor: 4.434

10.  Vaccination coverage among children in Germany estimated by analysis of health insurance claims data.

Authors:  Thorsten Rieck; Marcel Feig; Tim Eckmanns; Justus Benzler; Anette Siedler; Ole Wichmann
Journal:  Hum Vaccin Immunother       Date:  2013-11-05       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.